The review reveals major errors on the part of regulators, flawed health guidance recommendations, weak vaccine trials, underreporting of injury and a miscalculation of cost-benefit analysis.
Even using the limited information available to the public when the vaccines were introduced, it was evident that the manufacturers and regulators were being dishonest about safety. For instance, they claimed that the following incident that occurred during the trial was not related to the study product.
"A 25-year-old male with no past medical history and no concurrent medications experienced a transverse sinus thrombosis on Day 21 following vaccination. On Day 9 the participant experienced symptoms of fever, myalgia, headache, fatigue, abdominal pain, congestion and rhinorrhea. He tested negative for SARs-CoV-2 during this acute illness. Aside from headache, his symptoms improved. On Day 19 he experienced a tonic colonic seizure. A CT scan without contrast demonstrated a cerebral hemorrhage. On Day 21, a transverse sinus thrombosis was reported on a venogram. The participant underwent a thrombectomy as well as stent placement for stenosed right sigmoid sinus on Day 22. On Day 23 repeat venogram showed the presence of a new clot in the transverse sinus. A second thrombectomy with venoplasty was performed. Treating clinicians reported observing rapid thrombus formation during the two thrombectomy procedures that was consistent with a clinically hypercoagulable state. In their assessment, the transverse sinus thrombosis most likely occurred days before the participant's clinical presentation with a seizure; the seizure was reported to be a consequence of a secondary bleed caused by elevated venous pressure from the venous flow obstruction. Workup for hematologic and infectious causes of the thrombosis did not reveal an etiology. This event was initially thought to be related to the study product by the investigator and prompted a study pause. After thorough investigation and expert consultation no clear cause of the event was identified; however possible contributing factors, such as preceding infection and an anatomical anomaly, were suggested. The investigator’s brochure and informed consent form were updated accordingly, and the study pause was lifted. The investigator and Sponsor’s final assessment of this event was that it was not related to the study product."
SOURCE:
Vaccines and Related Biological Products Advisory Committee Meeting
February 26, 2021
FDA Briefing Document
Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19
Have you ever wondered why the supposed regulatory agencies like the CDC, NIH, FDA etc have been complicit in the whole covid plandemic nonsense? They are subsidiaries of US Department of Defense corporation. "Here is just a partial analysis of "Department of Defense" aka, "DOD", as a foreign commercial corporation controlling among other things:
NIH, CDC and FDA, Social Security, Health and Human Services including Indian Health, Railroads, National Transportation Safety, Bonneville Power, Nuclear Regulation Agency, DOE Petroleum Reserves, BLM, Bureau of Reclamation, DOEducation, FBI, DEA, DOJ, US Attorneys Army, Army Reserves, Corps of Engineers, Navy Exchange Service Command, Air Force, NSA, Secretary of Defense, Civilian Personnel Advisory Service, Strategic Command, and "Congress" --meaning the British Territorial United States "Congress"--- are under DOD."
Medrxiv is down.
Let‘s hope it comes up again.
Found it there:
https://www.researchgate.net/publication/366099520_Serious_harms_of_the_COVID-19_vaccines_a_systematic_review/fulltext/6391dc31484e65005bf45ca2/Serious-harms-of-the-COVID-19-vaccines-a-systematic-review.pdf
Even using the limited information available to the public when the vaccines were introduced, it was evident that the manufacturers and regulators were being dishonest about safety. For instance, they claimed that the following incident that occurred during the trial was not related to the study product.
"A 25-year-old male with no past medical history and no concurrent medications experienced a transverse sinus thrombosis on Day 21 following vaccination. On Day 9 the participant experienced symptoms of fever, myalgia, headache, fatigue, abdominal pain, congestion and rhinorrhea. He tested negative for SARs-CoV-2 during this acute illness. Aside from headache, his symptoms improved. On Day 19 he experienced a tonic colonic seizure. A CT scan without contrast demonstrated a cerebral hemorrhage. On Day 21, a transverse sinus thrombosis was reported on a venogram. The participant underwent a thrombectomy as well as stent placement for stenosed right sigmoid sinus on Day 22. On Day 23 repeat venogram showed the presence of a new clot in the transverse sinus. A second thrombectomy with venoplasty was performed. Treating clinicians reported observing rapid thrombus formation during the two thrombectomy procedures that was consistent with a clinically hypercoagulable state. In their assessment, the transverse sinus thrombosis most likely occurred days before the participant's clinical presentation with a seizure; the seizure was reported to be a consequence of a secondary bleed caused by elevated venous pressure from the venous flow obstruction. Workup for hematologic and infectious causes of the thrombosis did not reveal an etiology. This event was initially thought to be related to the study product by the investigator and prompted a study pause. After thorough investigation and expert consultation no clear cause of the event was identified; however possible contributing factors, such as preceding infection and an anatomical anomaly, were suggested. The investigator’s brochure and informed consent form were updated accordingly, and the study pause was lifted. The investigator and Sponsor’s final assessment of this event was that it was not related to the study product."
SOURCE:
Vaccines and Related Biological Products Advisory Committee Meeting
February 26, 2021
FDA Briefing Document
Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19
https://www.fda.gov/media/146217/download
Well done, thank you for the summary. Cross-posted.
Slowly, I'm seeing more of my friends change their mind about the "safe and effective" idea...
Have you ever wondered why the supposed regulatory agencies like the CDC, NIH, FDA etc have been complicit in the whole covid plandemic nonsense? They are subsidiaries of US Department of Defense corporation. "Here is just a partial analysis of "Department of Defense" aka, "DOD", as a foreign commercial corporation controlling among other things:
NIH, CDC and FDA, Social Security, Health and Human Services including Indian Health, Railroads, National Transportation Safety, Bonneville Power, Nuclear Regulation Agency, DOE Petroleum Reserves, BLM, Bureau of Reclamation, DOEducation, FBI, DEA, DOJ, US Attorneys Army, Army Reserves, Corps of Engineers, Navy Exchange Service Command, Air Force, NSA, Secretary of Defense, Civilian Personnel Advisory Service, Strategic Command, and "Congress" --meaning the British Territorial United States "Congress"--- are under DOD."
Continue reading here: http://www.paulstramer.net/2023/03/getting-caught-up-after-160-plus-years.html